Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy

Stem Cells

Volumn 15, Issue SUPPL. 1, 1997, Pages 113-120

  Tidow, Nicola ^a   Pilz, Christina ^a   Kasper, Brigitte ^a   Welte, Karl ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

G CSF receptor mutations; G CSF treatment; Severe congenital neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

APLASTIC ANEMIA; CONFERENCE PAPER; DISEASE SEVERITY; GENE EXPRESSION; KALLMANN SYNDROME; NEUTROPENIA; POINT MUTATION; RECEPTOR GENE;

ADULT; AMINO ACID SEQUENCE; ANEMIA, APLASTIC; BASE SEQUENCE; CHILD; CHRONIC DISEASE; DNA MUTATIONAL ANALYSIS; FILGRASTIM; GENES; HUMANS; LEUKEMIA, MYELOID; MOLECULAR SEQUENCE DATA; NEUTROPENIA; POINT MUTATION; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR;

EID: 0030690977     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530150815     Document Type: Article

References (23)

1. Kostmann RRO. Infantile genetic agranulocytosis (agranulocytosis infantilis hereditaria): a new recessive lethal disease in man. Acta Paediatr Scand 1956;45:1-78.
2. Kostmann RRO. Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Paediatr Scand 1975;64:362-368.
3. Bonilla MA, Gillio AP, Ruggeiro M et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574-1580.
4. Welte K, Zeidler C, Reiter A et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 1990;75:1056-1063.
5. Dale DC, Bonilla MA, Davis MW et al. A randomized controlled phase-III trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia. Blood 1993;81:2496-2502.
6. Bonilla MA, Dale D, Zeidler C et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenia. Br J Haematol 1994;88:723-730.
7. Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol 1996;72:158-165.
8. Welte K, Boxer LA. Severe chronic neutropenia: pathophysiology and therapy. Semin Hematol 1997 (in press).
9. Rosen R, Kang S. Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J Pediatr 1979;94:406-408.
10. Rauprich P, Kasper B, Tidow N et al. The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia. Blood 1995;86:4500-4505.
11. Dong F, Brynes RK, Tidow N et al. Mutations in the gene for the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia preceded by severe consenital neutropenia. N Engl J Med 1995;333:487-493.
12. Tidow N, Pilz C, Teichmann B et al. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood 1997;89:2369-2375.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-169.
14. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalysed chain reaction. Methods Enzymol 1987;155;335-350.
15. Chien A, Edgar DB, Trela JM. Deoxyribonucleic acid polymerase from the extreme thermophile Thermus aquaticus. J Bacteriol 1976;127:1550-1557.
16. Fukunaga R, Seto Y, Mizushima S et al. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci USA 1990;87:8702-8706.
17. Sanger F, Miklen S, Coulson AR. DNA sequencing with chain termination inhibitors. Proc Natl Acad Sci USA 1977;74:5463-5467.
18. Dong F, Hoefsloot LH, Schelen AM et al. Identification of a nonsense mutation in the granulocyte colony- stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA 1994;91;4480-4484.
19. Touw IP, de Koning JP, Löwenberg B et al. Defective G-CSF receptors in severe congenital neutropenia (SCN) associated with progression towards MDS and AML. Blood 1995;86(suppl 1):26a.
20. Kalra R, Dale D, Freedman M et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 1995;86:4579-4586.
21. Fukunaga R, Ishizaka-Ikeda E, Pan CX et al. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 1991;10:2855-2865.
22. Fukunaga R, Ishizaka-Ikeda E, Nagata S. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 1993;74:1079-1087.
23. Dong F, van Buitenen C, Pouwels K et al. Distinct cytoplasmic regions of the human G-CSF receptor involved in transduction of proliferative and maturation signals. Mol Cell Biol 1993;13:7774-7781.